Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
TBP Study With Capecitabine Plus Minus Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE3
Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3